Market Cap

Lineage Cell Therapeutics, Inc. Market Capitalization:

$377.7 Million

USD as of Jan. 1, 2026

business Lineage Cell Therapeutics, Inc. Company Profile

Lineage Cell Therapeutics, Inc. Main Stock Listing

NYSE: LCTX

Market Capitalization History of Lineage Cell Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Lineage Cell Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $377.7 M 169.46%
Jan. 1, 2025 $140.2 M -33.24%
Jan. 1, 2024 $210.0 M -19.26%
Jan. 1, 2023 $260.1 M -8.23%
Jan. 1, 2022 $283.4 M -28.51%
Jan. 1, 2021 $396.4 M 114.56%
Jan. 1, 2020 $184.7 M -26.95%
Jan. 1, 2019 $252.9 M -51.55%
Jan. 1, 2018 $521.9 M -7.03%
Jan. 1, 2017 $561.4 M 29.34%
Jan. 1, 2016 $434.0 M -40.69%
Jan. 1, 2015 $731.8 M 9.68%
Jan. 1, 2014 $667.2 M -19.13%
Jan. 1, 2013 $825.0 M -20.42%
Jan. 1, 2012 $1.04 B -26.18%
Jan. 1, 2011 $1.40 B 53.23%
Jan. 1, 2010 $916.5 M 127.11%
Jan. 1, 2009 $403.5 M 733.33%
Jan. 1, 2008 $48.4 M -48.08%
Jan. 1, 2007 $93.3 M 23.81%
Jan. 1, 2006 $75.3 M -67.69%
Jan. 1, 2005 $233.2 M -17.20%
Jan. 1, 2004 $281.6 M -4.85%
Jan. 1, 2003 $295.9 M -60.71%
Jan. 1, 2002 $753.3 M -56.70%
Jan. 1, 2001 $1.74 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Stocks & Indices

Lineage Cell Therapeutics, Inc. has the following listings and related stock indices.


Stock: NYSE: LCTX

Stock: FSX: BT3

Stock: TASE: LCTX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.